HEALTH CARE DECISION MAKERS OPEN FOR PUBLIC AND PATIENT INVOLVEMENT IN COVERAGE DECISIONS

Published Apr 10, 2015
Brussels, Belgium – In a democratic system, politicians are elected to make decisions regarding health care priorities. In deliberation-driven systems, such as in Belgium, coverage decisions are based on the outcomes of a deliberation amongst stakeholders (including public authorities, providers, academics, and sickness funds). Patients and citizens are rarely –if-ever- directly involved in this process. Should citizens and patients be involved more intensively? If so, how?  To find out, researchers from the Belgian Health Care Knowledge Centre (KCE) performed a two-round Delphi survey on Belgian stakeholders currently involved or not (yet) involved in the decision-making processes. Eighty people participated in both rounds. The Delphi panel of participants consisted of politicians on national, regional and local level, members of advisory committees, patient organisations, and consumer organisations. Panel participants preferred citizens and patients to be consulted within the existing structures and at particular milestones in the process. Justification should be provided when decisions deviate from the recommendation of the public or patients. The researchers feel that further research is needed regarding the effectiveness of public and patient involvement strategies. Irina Cleemput, PhD, senior health economist, explains, “The panel reached consensus on the importance of public and patient involvement in health care coverage decisions, however, they see different roles for patients and citizens. While citizens should be involved in determining the general priorities in health care, patients should be involved in coverage decisions as experts by experience.” The full study, “Acceptability and Perceived Benefits and Risks of Public and Patient Involvement in Health Care Policy: A Delphi Survey in Belgian Stakeholders,” is published in Value in Health.

Related Stories

Rethinking Medication Adherence: A Stakeholder Blueprint

May 12, 2025

Value in Health, the official journal of ISPOR—The Professional Society for Health Economics and Outcomes Research, announced today the publication of a report from its Medication Adherence and Persistence Special Interest Group that provides valuable insights into the perspectives of key stakeholders on interventions to improve medication adherence. The report, “Stakeholders’ Perspectives on Medication Adherence Enhancing Interventions: An ISPOR Report,” was published in the May 2025 issue of Value in Health.

New Research Reveals Surprising Trends in Women's Health Economics Authorship

May 12, 2025

Value in Health, the official journal of ISPOR announced the publication of new research analyzing women's representation in authorship of papers submitted to and published in Value in Health. The report, “How Well Are Women Represented in Authorship in HEOR? An Analysis of Value in Health: An ISPOR Report,” was published in the May 2025 issue of Value in Health.

Redefining Value in Care for Alzheimer's Disease and Dementia

Apr 8, 2025

Value in Health, the official journal of ISPOR—The Professional Society for Health Economics and Outcomes Research, announced the publication of a special themed section of research papers that provide crucial insights into the complex health economics of Alzheimer's disease and related dementias (ADRD), offering a roadmap for future research and policy as the aging population grows and novel treatments emerge.
Your browser is out-of-date

ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now

×